정신병 위험상태 : 관련된 문제와 향후 전망

참고문헌 (54)

1. Hegarty JD, "One hundred years of schizophrenia: a meta-analysis of the outcome literature", Am J Psychiatry, 151, pp.1409~1416 (1994)
2. McGorry PD, "Issues for DSM-V: clinical staging: a heuristic pathway to valid nosology and safer, more effective treatment in psychiatry", Am J Psychiatry, 164, pp.859~860 (2007)
3. Arango C, "Attenuated psychotic symptoms syndrome: how it may affect child and adolescent psychiatry", Eur Child Adolesc Psychiatry, 20, pp.67~70 (2011)
4. McGorry PD, "Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions", Aust N Z J Psychiatry, 40, pp.616~622 (2006)
5. McGorry PD, "Spurious precision: procedural validity of diagnostic assessment in psychotic disorders", Am J Psychiatry, 152, pp.220~223 (1995)
6. Carpenter WT, "Anticipating DSM-V: should psychosis risk become a diagnostic class", Schizophr Bull, 35, pp.841~843 (2009)
7. Pincus HA, "Subthreshold mental disorders: Nosological and research recommendations. Advancing DSM: Dilemmas in Psychiatric Diagnosis", pp.129~144 (2003), American Psychiatric Association
8. Meares A, "The diagnosis of prepsychotic schizophrenia", Lancet, 1, pp.55~58 (1959)
9. Olin SC, "School teacher ratings predictive of psychiatric outcome 25 years later", Br J Psychiatry Suppl, 172, pp.7~13 (1998)
10. Häfner H, "The course of schizophrenia in the light of modern follow-up studies: the ABC and WHO studies", Eur Arch Psychiatry Clin Neurosci, 249(4), pp.14~26 (1999)
11. Häfner H, "Causes and consequences of the gender difference in age at onset of schizophrenia", Schizophr Bull, 24, pp.99~113 (1998)
12. Verdoux H, "Schizophrenia: who is at risk? Who is a case", Int Clin Psychopharmacol, 21(2), pp.S17~S19 (2006)
13. Drake RJ, "Early detection of schizophrenia", Curr Opin Psychiatry, 18, pp.147~150 (2005)
14. Corcoran CM, "The psychosis risk syndrome and its proposed inclusion in the DSM-V: a risk-benefit analysis", Schizophr Res, 120, pp.16~22 (2010)
15. Yung AR, "Prediction of psychosis. A step towards indicated prevention of schizophrenia", Br J Psychiatry Suppl, 172, pp.14~20 (1998)
16. Yung AR, "The initial prodrome in psychosis: descriptive and qualitative aspects", Aust N Z J Psychiatry, 30, pp.587~599 (1996)
17. Yung AR, "Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States", Aust N Z J Psychiatry, 39, pp.964~971 (2005)
18. Miller TJ, "Symptom assessment in schizophrenic prodromal states", Psychiatr Q, 70, pp.273~287 (1999)
19. Gross G, "The ‘basic’ symptoms of schizophrenia", Br J Psychiatry Suppl, (25), pp.21~25 (1989)
20. Schultze-Lutter F, "Predicting first-episode psychosis by basic symptom criteria", Clin Neuropsychiatry, 4, pp.11~22 (2007)
21. Yung AR, "Should a “Risk Syndrome for Psychosis” be included in the DSMV", Schizophr Res, 120, pp.7~15 (2010)
22. Woods SW, "The case for including Attenuated Psychotic Symptoms Syndrome in DSM-5 as a psychosis risk syndrome", Schizophr Res, 123, pp.199~207 (2010)
23. Wong C, "Stigma in families of individuals in early stages of psychotic illness: family stigma and early psychosis", Early Interv Psychiatry, 3, pp.108~115 (2009)
24. Cosgrove L, "Developing unbiased diagnostic and treatment guidelines in psychiatry", N Engl J Med, 360, pp.2035~2036 (2009)
25. Cannon TD, "Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America", Arch Gen Psychiatry, 65, pp.28~37 (2008)
26. Niendam TA, "Exploring predictors of outcome in the psychosis prodrome: implications for early identification and intervention", Neuropsychol Rev, 19, pp.280~293 (2009)
27. Norman RM, "Duration of untreated psychosis: a critical examination of the concept and its importance", Psychol Med, 31, pp.381~400 (2001)
28. Marshall M, "Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review", Arch Gen Psychiatry, 62, pp.975~983 (2005)
29. Perkins DO, "Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis", Am J Psychiatry, 162, pp.1785~1804 (2005)
30. Walterfang M, "Corpus callosum shape alterations in individuals prior to the onset of psychosis", Schizophr Res, 103, pp.1~10 (2008)
31. Takahashi T, "Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis", Arch Gen Psychiatry, 66, pp.366~376 (2009)
32. Lappin JM, "Duration of prodromal phase and severity of volumetric abnormalities in first-episode psychosis", Br J Psychiatry Suppl, 51, pp.s123~s127 (2007)
33. Zipparo L, "Investigating the neuropsychological and neuroanatomical changes that occur over the first 2-3 years of illness in patients with first-episode schizophrenia", Prog Neuropsychopharmacol Biol Psychiatry, 32, pp.531~538 (2008)
34. Woods SW, "Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study", Schizophr Bull, 35, pp.894~908 (2009)
35. Schultze-Lutter F, "The schizophrenia prediction instrument, adult version (SPI-A)", Schizophr Res, 70, pp.76~77 (2004)
36. Yung AR, "Validation of “prodromal” criteria to detect individuals at ultra high risk of psychosis: 2 year follow-up", Schizophr Res, 105, pp.10~17 (2008)
37. Ruhrmann S, "Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study", Arch Gen Psychiatry, 67, pp.241~251 (2010)
38. Yung AR, "The prevention of schizophrenia", Int Rev Psychiatry, 19, pp.633~646 (2007)
39. Correll CU, "Research in people with psychosis risk syndrome: a review of the current evidence and future directions", J Child Psychol Psychiatry, 51, pp.390~431 (2010)
40. Haroun N, "Risk and protection in prodromal schizophrenia: ethical implications for clinical practice and future research", Schizophr Bull, 32, pp.166~178 (2006)
41. Ruhrmann S, "Intervention in the at-risk state to prevent transition to psychosis", Curr Opin Psychiatry, 22, pp.177~183 (2009)
42. Morrison AP, "Cognitive therapy for the prevention of psychosis in people at ultra-high risk: randomised controlled trial", Br J Psychiatry, 185, pp.291~297 (2004)
43. Lee SY, "Grape cognitive therapy for isolation, wandering, confusion, misinterpretation, and unfamiliar voice.: expert manual" (2011), Hakjisa
44. Kim KR, "Clinical efficacy of individual cognitive therapy in reducing psychiatric symptoms in people at ultra-high risk for psychosis", Early Interv Psychiatry, 5, pp.174~178 (2011)[DOI]
45. McGlashan TH, "Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis", Am J Psychiatry, 163, pp.790~799 (2006)
46. Amminger GP, "Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial", Arch Gen Psychiatry, 67, pp.146~154 (2010)
47. Greene T, "The Kraepelinian dichotomy: the twin pillars crumbling", Hist Psychiatry, 18, pp.361~379 (2007)
48. Wyatt RJ, "Schizophrenia, just the facts. What do we know, how well do we know it", Schizophr Res, 1, pp.3~18 (1988)
49. Tandon R, "Schizophrenia, “just the facts” 4. Clinical features and conceptualization", Schizophr Res, 110, pp.1~23 (2009)
50. Robins E, "Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia", Am J Psychiatry, 126, pp.983~987 (1970)
51. Haahr U, "First-episode psychosis: diagnostic stability over one and two years", Psychopathology, 41, pp.322~329 (2008)
52. Jakobsen KD, "Diagnostic agreement of schizophrenia spectrum disorders among chronic patients with functional psychoses", Psychopathology, 39, pp.269~276 (2006)
53. Ruhrmann S, "Acute effects of treatment for prodromal symptoms for people putatively in a late initial prodromal state of psychosis", Br J Psychiatry Suppl, 51, pp.s88~s95 (2007)
54. "A decade for psychiatric disorders", Nature, 463, pp.9~ (2010)

관련 논문AI추천